Literature DB >> 24867827

Migraine attacks in the pharmacy: a survey in Piedmont, Italy.

P Brusa1, G Allais, G Bussone, S Rolando, M Giaccone, M Aguggia, C Benedetto.   

Abstract

Headache patients often consult a pharmacist in an attempt to obtain momentary pain relief without having been given any previous expert advice. A specific questionnaire was distributed to the pharmacies in order to assess the patterns of use and dispensing of analgesic medications to the headache patient who turns to the pharmacist for relief of a painful attack. This study aimed at identifying migraine patients who self-medicated, with further end points including whether these patients shared any particular clinical characteristics, the most common type of analgesic medications used, and what, if anything, was recommended by the pharmacist; lastly, which health care professional, if any, routinely managed the patient's headaches. A total of 9,100 questionnaires were distributed to the pharmacies and the complete 3,065 were included in the database. The ID Migraine Screener Test was used to classify subjects into 4 groups: "Definite migraine" (3/3 positive answers: n = 1,042; 34 %), "Probable migraine" (2/3: n = 969; 31.6 %), "Unlikely migraine" (1/3: n = 630; 20.5 %), and "Other headaches" (0/3: n = 424; 13.8 %). Only Definite and Probable migraines (n = 2,011) are considered in this paper. Amongst the drugs usually taken by the patients, NSAIDs were more common in the Probable migraine group (60.7 %) than in the Definite migraine (44.7 %) group (p < 0.001). On the contrary, triptans were more commonly used by the Definite migraine group (42.9 %) than the Probable migraine (23.7 %) group (p < 0.001), and combination drugs were preferentially (p < 0.001) chosen by the Definite (13.8 %) rather than the Probable migraine group (8.7 %). A total of 29.2 % of respondents reported that for the management of their headaches, they did not avail themselves of any type of professional healthcare, such as their general practitioner, a headache specialist, or a Headache Center.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24867827     DOI: 10.1007/s10072-014-1733-5

Source DB:  PubMed          Journal:  Neurol Sci        ISSN: 1590-1874            Impact factor:   3.307


  5 in total

Review 1.  The methodology of population surveys of headache prevalence, burden and cost: principles and recommendations from the Global Campaign against Headache.

Authors:  Lars Jacob Stovner; Mohammed Al Jumah; Gretchen L Birbeck; Gopalakrishna Gururaj; Rigmor Jensen; Zaza Katsarava; Luiz Paulo Queiroz; Ann I Scher; Redda Tekle-Haimanot; Shuu-Jiun Wang; Timothy J Steiner
Journal:  J Headache Pain       Date:  2014-01-27       Impact factor: 7.277

2.  A self-administered screener for migraine in primary care: The ID Migraine validation study.

Authors:  R B Lipton; D Dodick; R Sadovsky; K Kolodner; J Endicott; J Hettiarachchi; W Harrison
Journal:  Neurology       Date:  2003-08-12       Impact factor: 9.910

Review 3.  Medication overuse headache: history, features, prevention and management strategies.

Authors:  Joel R Saper; Arnaldo Neves Da Silva
Journal:  CNS Drugs       Date:  2013-11       Impact factor: 5.749

4.  ID-migraine.

Authors:  A M Rapoport; M E Bigal
Journal:  Neurol Sci       Date:  2004-10       Impact factor: 3.307

5.  Should we educate about the risks of medication overuse headache?

Authors:  James T F Lai; John D C Dereix; Ravi P Ganepola; Peter G Nightingale; Kiera A Markey; Paul N Aveyard; Alexandra J Sinclair
Journal:  J Headache Pain       Date:  2014-02-13       Impact factor: 7.277

  5 in total
  4 in total

1.  Community pharmacies as epidemiological sentinels of headache: first experience in Italy.

Authors:  Paola Brusa; Marco Parente; Gianni Allais; Sara Rolando; Giuseppe Costa; Roberto Gnavi; Teresa Spadea; Mario Giaccone; Andrea Mandelli; Massimo Mana; Francesca Baratta; Chiara Benedetto; Gennaro Bussone
Journal:  Neurol Sci       Date:  2017-05       Impact factor: 3.307

2.  Exploring community pharmacists' experiences of surveying patients for drug utilization research purposes.

Authors:  Pia Frisk; Ulrika Bergman; Sofia Kälvemark-Sporrong
Journal:  Int J Clin Pharm       Date:  2015-03-04

3.  Migraine attacks in the pharmacy: a gender subanalysis on treatment preferences.

Authors:  P Brusa; G Allais; S Rolando; F Baratta; M Giaccone; G Bussone; R Allais; C Benedetto
Journal:  Neurol Sci       Date:  2015-05       Impact factor: 3.307

4.  Self-medication for migraine: A nationwide cross-sectional study in Italy.

Authors:  Paola Brusa; Gianni Allais; Cecilia Scarinzi; Francesca Baratta; Marco Parente; Sara Rolando; Roberto Gnavi; Teresa Spadea; Giuseppe Costa; Chiara Benedetto; Massimo Mana; Mario Giaccone; Andrea Mandelli; Gian Camillo Manzoni; Gennaro Bussone
Journal:  PLoS One       Date:  2019-01-23       Impact factor: 3.240

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.